Ajooni Biotech
NSE: AJOONI · ISIN INE820Y01021 · Consumer Defensive
₹2.86−0.13 (−4.35%)
Monday 9 November, 12:04 IST. Delayed. Source: Yahoo Finance.
Price chart
₹2.86 −0.13 (−4.35%) today
The day
- Previous close
- ₹2.99
- Open
- ₹2.99
- Day high
- ₹3.00
- Day low
- ₹2.78
Listed on NSE since 7 May 2021.
Key numbers
- Market value
- ₹50.98 Cr
- P/E (trailing)
- 11.84
- EPS (trailing)
- ₹0.25
- Price to book
- 0.56
- Dividend yield
- 0.00%
- Return on equity
- 4.4%
- Debt to equity
- 0.29
- Profit margin
- 1.9%
- Beta
- 0.38
- Volume today
- 5.84 L
- Average volume
- 3.22 L
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹74.49 Cr | ₹1.12 Cr |
| FY24 | ₹80.11 Cr | ₹2.16 Cr |
| FY25 | ₹114.69 Cr | ₹3.37 Cr |
| FY26 | ₹182.38 Cr | ₹4.32 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported. EPS before FY25 is not shown: the share count changed (a bonus, split or merger), so earlier figures would not compare.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | ₹63 Cr | ₹43.18 L | −44.7% |
| Q4 FY26Jan–Mar 2026Audited | ₹61 Cr | ₹94.72 L | −38.6% |
| Q3 FY26Oct–Dec 2025 | ₹59 Cr | ₹2 Cr | – |
| Q2 FY26Jul–Sep 2025 | ₹32 Cr | ₹93.21 L | – |
| Q1 FY26Apr–Jun 2025 | ₹31 Cr | ₹78.14 L | – |
| Q4 FY25Jan–Mar 2025Audited | ₹29 Cr | ₹2 Cr | – |
Source: Ajooni Biotech’s results filed with NSE, standalone (the company alone). Net profit is the share of Ajooni Biotech’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss. EPS before Q1 FY27 is not shown: the share count changed (a bonus, split or merger), so it would not compare.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | March 2026 | September 2025 |
|---|---|---|
| Fixed assets | ₹26 Cr | ₹22 Cr |
| Investments | ₹2 Cr | ₹3 Cr |
| Inventories | ₹39 Cr | ₹23 Cr |
| Owed by customers | ₹18 Cr | ₹16 Cr |
| Cash and equivalents | ₹41.90 L | ₹15 Cr |
| Total assets | ₹120 Cr | ₹104 Cr |
| Borrowings | ₹18 Cr | ₹9 Cr |
| Total liabilities | ₹29 Cr | ₹14 Cr |
| Shareholders’ equity | ₹91 Cr | ₹90 Cr |
Source: Ajooni Biotech’s half-yearly statements of assets and liabilities filed with NSE, standalone. Companies file these every September and March.
About Ajooni Biotech
Ajooni Biotech Limited provides animal nutrition and animal healthcare solutions in India. It offers compound cattle feed, cattle feed chips, came feed, cotton oil cake, mustard oil cake, and a range of feed supplements to support the nutritional requirements of livestock. Ajooni Biotech Limited was incorporated in 2010 and is based in Mohali, India.
- Industry
- Packaged Foods
- Based in
- Mohali
- Employees
- 182
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Ajooni Biotech in the last day or two.
Dividends and corporate actions
All companies- Annual General Meeting
Action · ex-date 10 September 2024
- Rights 1:1 @ Premium Rs 3/-
Right · ex-date 7 May 2024
- Annual General Meeting
Action · ex-date 29 August 2023
- Rights 29:30 @ Premium Rs 4/-
Right · ex-date 25 November 2022
- Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share
Split · ex-date 7 October 2022
- Annual General Meeting
Action · ex-date 13 September 2022
- Annual General Meeting
Action · ex-date 17 September 2021
Source: NSE. Latest first.
Information only, not investment advice. Prices are delayed.